Globus Medical does not currently pay regular cash dividends to its common shareholders, choosing instead to deploy its substantial free cash flows and earnings back into the business. Management prioritizes funding strategic research and development initiatives, expanding manufacturing infrastructure, pursuing value-enhancing corporate acquisitions, and executing opportunistic capital investments designed to accelerate long-term top-line growth and maximize overall enterprise value.